Innate Pharma S.A. (IPHYF)

USD 1.45

(7.41%)

Revenue Summary of Innate Pharma S.A.

  • Innate Pharma S.A.'s latest annual revenue in 2023 was 51.9 Million EUR , up 4.56% from previous year.
  • Innate Pharma S.A.'s latest quarterly revenue in 2024 Q2 was 6.17 Million EUR , down 0.0% from previous quarter.
  • Innate Pharma S.A. reported a annual revenue of 49.63 Million EUR in annual revenue 2022, up 309.83% from previous year.
  • Innate Pharma S.A. reported a annual revenue of 12.11 Million EUR in annual revenue 2021, down -78.69% from previous year.
  • Innate Pharma S.A. reported a quarterly revenue of 6.17 Million EUR for 2024 Q1, down -42.43% from previous quarter.
  • Innate Pharma S.A. reported a quarterly revenue of 35.34 Million EUR for 2023 Q2, up 75.85% from previous quarter.

Annual Revenue Chart of Innate Pharma S.A. (2023 - 2005)

Historical Annual Revenue of Innate Pharma S.A. (2023 - 2005)

Year Revenue Revenue Growth
2023 51.9 Million EUR 4.56%
2022 49.63 Million EUR 309.83%
2021 12.11 Million EUR -78.69%
2020 56.83 Million EUR -17.6%
2019 68.97 Million EUR -13.67%
2018 79.89 Million EUR 144.83%
2017 32.63 Million EUR -41.9%
2016 56.16 Million EUR 213.64%
2015 17.9 Million EUR 1874.2%
2014 907 Thousand EUR -92.73%
2013 12.46 Million EUR 20.16%
2012 10.37 Million EUR -11.61%
2011 11.74 Million EUR 171.76%
2010 4.32 Million EUR -44.01%
2009 7.71 Million EUR -40.3%
2008 12.92 Million EUR -9.56%
2007 14.29 Million EUR 130.67%
2006 6.19 Million EUR 376.54%
2005 1.3 Million EUR 0.0%

Peer Revenue Comparison of Innate Pharma S.A.

Name Revenue Revenue Difference
Bioxytran, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD -229.05%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD -141.647%
Intellipharmaceutics International Inc. 65.72 Thousand USD -78863.303%
Evofem Biosciences, Inc. 18.21 Million USD -184.889%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 57.788%
Propanc Biopharma, Inc. - USD -Infinity%
Marizyme, Inc. 645.81 Thousand USD -7936.574%
Genus plc 668.8 Million USD 92.24%
Pharming Group N.V. 245.31 Million USD 78.843%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -52328.43%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -12553.688%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -67513.762%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -131235.088%
ONE Bio Corp. 52.29 Million USD 0.756%
RVL Pharmaceuticals plc 49.72 Million USD -4.384%
Mesoblast Limited 5.9 Million USD -779.38%
MultiCell Technologies, Inc. 49.32 USD -105233071.127%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 29.59 Million USD -75.359%
Genscript Biotech Corporation 839.52 Million USD 93.818%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -294440.605%
Biomind Labs Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -9206.091%
Oncotelic Therapeutics, Inc. 70 Thousand USD -74044.286%
Skye Bioscience, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -68439.697%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -7781.701%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -106037.014%
Q BioMed Inc. 284.35 Thousand USD -18152.377%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.647%
Agentix Corp. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 64.231%
Enzolytics Inc. 52.79 Thousand USD -98204.796%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD -8428.984%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 95.768%
Northwest Biotherapeutics, Inc. 1.93 Million USD -2586.387%
HST Global, Inc. - USD -Infinity%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -5195195.295%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -36908.172%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Zenith Capital Corp. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -8306.599%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -5101.929%
Capstone Therapeutics Corp. 48.35 Million USD -7.335%
Kadimastem Ltd - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD -211.056%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -21839.888%
Regen BioPharma, Inc. 236.56 Thousand USD -21839.888%
Affymax, Inc. 1.36 Million USD -3691.161%
Mobile Lads Corp. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD -566.337%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -10855.819%
SYBLEU INC 11.69 Thousand USD -443650.0%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -399138.462%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -131181.935%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD -1458.589%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD -678.71%
IntelGenx Technologies Corp. 1.03 Million USD -4895.284%
Gelesis Holdings, Inc. 25.76 Million USD -101.424%
CSL Limited 14.8 Billion USD 99.649%
Cellectis S.A. 755 Thousand USD -6774.305%